Press: Important Information for Journalists

The DASGIP virtual pressroom is where journalists can locate press contacts or find key corporate information and images. Additional information about the company and current press releases are available under Company and News

.

World's First iPad™ Application for Online Bioreactor Control

To coincide with the launch of the iPad, DASGIP AG is expanding its Remote Control Suite for online bioreactor control with the introduction of its own iPad application.

Jülich, April 3, 2010 – DASGIP AG, a leading provider of parallel benchtop bioreactor systems, is now giving users of its technology online access to their bioprocesses via the iPad. The DASGIP iApp is one of the few industrial applications that will be premiered during the iPad App Store grand opening slated for April 3, 2010.
In contrast to other adapted iPhone applications, the DASGIP iApp is a universal application that is optimally designed for the iPad medium. "The Apple iPad, with its large touch screen and wide selection of display views, offers an outstanding platform for visualizing the processes that we monitor and control with our bioreactor systems," says Dr. Matthias Arnold, DASGIP Chief Scientific Officer. "By combining our hardware and software with the iPad, we are establishing milestones with respect to the user-friendliness and visualization of biotechnology processes."
The DASGIP iApp for the iPad allows users to monitor and control all relevant process values in up to 16 parallel reactors at different locations around the world in online mode. Users can enjoy a wide range of display options using different windows, zoom and rotation functions, all of which can be intuitively managed in typical Apple fashion. In the trend chart for instance, users can glance at the reference and process values as well as the control profile. They can also use the graphic timeline to browse around between historical and real-time process variable data in a stepless manner. Compared to pure web-based bioreactor monitoring, the iPad lets users mange their bioreactor systems with unsurpassed speed and ease.
The universal DASGIP iApp supports parallel remote access to globally-distributed bioreactor systems with the iPhone, iPod touch and iPad. Data security is ensured by utilizing VPN connectivity.

Images

The following images of the DASGIP management team and the company's products are made available for reporting purposes only. These high-resolution images may be downloaded and used for the specific purpose of reporting at no charge, provided that DASGIP AG is indicated as the source.

Management Team

DASGIP Management Board (right to left):
Dr. Thomas Drescher, President & CEO
Dr. Matthias Arnold, Chief Scientific Officer
Dr. Falk Schneider, Executive Vice President

DASGIP Supervisory Board:
Dr. Jürgen Kischoweit, Chairman of the Supervisory Board
Rolf Geisen, Member of the Supervisory Board
Dr. Helmut Hertz, Member of the Supervisory Board

» additional information about the management team

Products

Company Overview

DASGIP AG develops and manufactures technologically-superior parallel bioreactor systems designed for the lab-scale cultivation of bacterial, animal and human cells.
The current management board, which founded DASGIP in 1991, is headed by Dr. Thomas Drescher (President & CEO), Dr. Matthias Arnold (Chief Scientific Officer) and Dr. Falk Schneider (Executive Vice President).
The members of the supervisory board are Dr. Jürgen Kischoweit (Chairman), Rolf Geisen and Dr. Helmut Hertz.
The company is headquartered in Jülich, Germany. DASGIP Biotools LLC is a wholly-owned subsidiary with headquarters in Shrewsbury, MA (USA).

» additional information